Indian Stock Market Trends: Sensex & Nifty Plunge on Geopolitical Tensions
Budget 2026 STT bomb cratered Sensex 1,547 pts—but pharma & IT secretly surged! Will RBI’s rate cut save Nifty from 24k crash? ₹12Tn capex vs F&O bloodbath: Top 10 stocks to buy NOW exposed. Shocking gainers/losers + your Feb 2 playbook inside—don’t trade blind!
Indian markets kick off Monday, February 2, 2026, with cautious optimism after Friday’s Budget rout, as GIFT Nifty hints at a flat-to-positive start around 24,888 amid global mixed cues. This briefing unpacks the freshest data up to 8:24 AM IST, blending market prediction India, bluechip stock picks, and inflation trends India for savvy investors seeking edge in volatile times.
Indian Market Overview
BSE Sensex and NSE Nifty remain under pressure from Feb 1 special session, with Sensex closing at 80,723 (down 1,547 pts or 1.88%) and Nifty at 24,825 (down 495 pts). Bank Nifty trend shows weakness at 59,300 (down 2%), hit by PSU banks like SBI (-5.31%).
Investor sentiment is mixed: FIIs net sellers ₹4,500 Cr last week, but DIIs bought ₹3,200 Cr; VIX at 14%+ signals wariness pre-RBI MPC Feb 4-6. Experts like Sudeep Shah (SBI Sec) eye Nifty support at 24,650-24,500, with rebound potential to 25,000 if Budget digestion completes.
Key Economic Drivers
India’s GDP growth trajectory shines at 7.4% FY26 forecast, propelled by 9.2% Q2 corporate revenue YoY (ICRA sample), with infra/consumption leading. CPI inflation at 1.33% Dec (food-driven), well under RBI 4.6% upper band, fueling 25 bps repo cut bets Feb MPC.
RBI repo rates steady at 5.25%, down 75 bps in 2025; easing cycle continues amid 4.8% unemployment (Dec), bolstering rural demand. These drivers link to market movement: Low inflation cushions volatility, GDP supports capex plays despite Budget STT hike.
NIFTY Today in Detail
- Pre-Open (GIFT Nifty): +31 pts at 24,888 (0.13%), signaling flat open post-Budget.
- Expected Open: Nifty 24,850-24,900; Sensex 80,800 amid low volumes early Monday.
- Key Levels: Support 24,650/24,500; Resistance 25,000/25,150.
- Sentiment Indicators: VIX 14.5%; F&O OI buildup in calls at 25,000.
- Focus: Q3 previews, RBI policy; advances/declines skewed negative Feb 1 (1,054 up vs 2,073 down).
- Turnover Outlook: Equity ₹1.17 lakh Cr Feb 1; expect pickup with news flow.
Watch 9:15 AM open for direction.
BSE Sensex and Nifty 50 Trends February 2026
| Metric | BSE Sensex (Feb 1) | NSE Nifty 50 (Feb 1) | Feb MTD % | YTD 2026% | Commentary |
| Close | 80,723 [-1] | 24,825 | -3.5% | +6.2% | Budget correction from Jan highs |
| Intraday Range | 82,727-79,899 | 25,442-24,572 | Volatile | Peak early Jan | STT triggered plunge |
| Daily % | -1.88% | -1.96% | Nifty weaker | FPI ₹20k Cr out | Banking drag |
| Technicals | Support 80,000 | Support 24,500 | Rangebound | RSI oversold | Rebound if >25k |
| Volume (Cr Shrs) | High F&O | 530 Cr equity | Elevated | – | OI 2.26 Cr |
Sensex edges resilient via weights; Nifty broader pain; Feb tests 24k floor.
Impact of Budget 2026-27 on Stock Market
Budget 2026-27, presented by Finance Minister Nirmala Sitharaman on February 1, 2026, triggered an immediate market reaction with BSE Sensex dropping 1,547 points (1.88%) to 80,723 and NSE Nifty 50 falling 495 points (1.96%) to 24,825 during the special trading session. The budget balanced fiscal prudence with growth initiatives but disappointed on tax relief, leading to a ₹10 lakh crore market cap erosion. Below is a detailed, point-wise analysis of its stock market impacts, drawing from official documents and market responses.
Negative Impacts (Short-Term Sell-Off Triggers)
- STT Hike on Derivatives: STT on futures raised from 0.02% to 0.05%; options premium from 0.1% to 0.15%; options exercise from 0.125% to 0.15% – doubled/raised trading costs, widening F&O break-evens by 20-30%, slashing volumes (expected 30-50% drop), and hammering brokerages/exchanges. BSE shares plunged up to 13.5%, Angel One/Groww -18%; retail F&O participation (90% loss-makers) hit hardest.
- No Capital Gains Tax Relief: No cut in LTCG/STCG rates (despite expectations); buybacks now taxed as capital gains for all shareholders, curbing corporate payouts and irking retail/midcap investors. Contributed to broad risk-off, midcaps down 2.8%.
- 'Sin' Taxes and Consumption Drag: Higher levies on tobacco/alcohol pressured FMCG; ITC fell 4.35%, Nestle -4.61%, Tata Consumer -4.31% amid weak rural demand signals. Consumer goods sector -2.5%.
- PSU and Energy Slump: Flatish allocations amplified selling; ONGC -5.50%, Coal India -4.87%; metals like Hindalco -5.78% on no specific boosts amid global commodity weakness.
- Liquidity Squeeze: Higher STT reduces liquidity, weighs on multiples; India VIX surged 14% to 14.5%, signaling volatility ahead.
Positive Impacts (Sectoral Winners and Long-Term Boosts)
- Capex Surge to ₹12.2 Lakh Cr (9-11% YoY up from ₹11.2 Lakh Cr): Highest ever at 4.4% GDP; roads ₹2.9 Lakh Cr, railways ₹2.8 Lakh Cr – cheers infra/industrials (L&T -3.36% but order visibility up); supports 9.2% Q2FY26 revenue growth (ICRA). Dedicated freight corridor, 7 high-speed rails to benefit logistics.
- Defence Allocation Up 15.3% to ₹7.84 Lakh Cr (from ₹6.81 Lakh Cr): Capital outlay ₹2.19 Lakh Cr for weapons/electronics; aids HAL/BEL long-term despite intraday -6% dips on unmet super-hike hopes; DAP 2020/DPM 2025 streamline procurement.
- Healthcare and Pharma Push – ₹1.06 Lakh Cr Total, ₹10,000 Cr 'Bio Pharma Shakti' Over 5 Yrs: Biologics/biosimilars production, clinical trials network, pharma institutes; duty exemptions on 17 cancer/rare disease drugs – Sun Pharma +0.86%, Cipla +1.44%, Dr Reddy's resilient; reduces import dependence.
- Fiscal Deficit at 4.3% GDP (RE 2025-26: 4.4%): Prudent glide path (debt/GDP 55.6%); boosts ratings, eases bond yields, aids RBI cuts; non-debt receipts ₹34 Lakh Cr strong.
- Other Tailwinds: TCS on LRS/education reduced to 2%; PROI FDI limit up (individual 5→10%, aggregate 10→24%); semiconductors/rare earths/clean tech policy pushes (Tata Elxsi/Bharat Electronics).
Sector-Wise Stock Reactions (Feb 1 Special Session)
| Sector | Key Budget Trigger | Top Movers (% Chg) | Outlook |
| Brokerages | STT F&O Hike | BSE/Angel One -13-18% | Negative short-term |
| Infra/Industrials | ₹12.2 Tn Capex | L&T -3.36%; positives long-term | Buy dip |
| Defence | ₹7.84 Tn (+15%) | BEL -6.02%, HAL dip | Selective |
| Pharma/Health | Bio Shakti ₹10k Cr, duty cuts | Sun +0.86%, Cipla +1.44% | Bullish |
| FMCG | Sin taxes | ITC -4.35%, Nestle -4.61% | Cautious |
| Metals/Energy | No boosts | Hindalco -5.78%, ONGC -5.50% | Weak |
Net Market Impact and Forward Outlook
- Immediate: Sharp correction (Nifty below 24,850 first time in weeks); FII selling intensified, but DIIs absorbed ₹3,200 Cr. Turnover high at ₹1.17 Lakh Cr equity.
- Medium-Term: STT curbs speculation (positive structurally), capex/GDP alignment (7.4% FY26) supports recovery; RBI MPC Feb 4-6 (25 bps cut odds) key catalyst.
- Long-Term: Growth-oriented (infra/health/defence) aligns with Viksit Bharat; fiscal glide aids debt sustainability (50% GDP tgt 2031). Experts: Short pain, buy infra/pharma dips; avoid overleveraged F&O.
This budget prioritizes consolidation over populism, setting stage for sustainable bull run if macros hold.
Latest News Highlights
Indian markets gear up for a flat-to-positive open on Monday, with GIFT Nifty +31 pts at 24,888 (0.13%), recovering from Budget 2026's STT shock that erased ₹10 lakh Cr mcap Feb 1. Selective buying emerges in resilient sectors amid Q3 earnings and RBI MPC buzz; BSE/NSE mcap ₹448 Tn (-2%). Here's the top breakdown with point-wise impacts:
STT F&O Fallout Continues
- BSE/NSDL shares in focus (-13-18% Feb 1); market leaders urge rollback for liquidity; Nifty Feb futures at 24,792 (-2.46%), OI max call 26k/put 24k.
- Impact: Volatility persists (VIX 14.5%); F&O OI 2.26 Cr contracts; short-term broker pain, structural speculation curb positive.
Capex Infra Push Fuels Recovery Bets
- ₹12.22 Tn capex (9-11% YoY, 4.4% GDP) validates 9.2% Q2 rev growth (ICRA); roads ₹2.9 Tn, rails ₹2.8 Tn, freight corridors boost L&T (-3.36% Feb1 but orders up).
- Gross borrowing ₹17.2 Tn (net ₹11.7 Tn FY27) higher than est., eyes banks; infra theme intact with GDP 7.4% FY26.
- Impact: Buy dips in industrials (RVNL/Suzlon watch); long-term multiplier for growth stocks.
Defence Steady, Not Flat – Selective Action
- Allocation +15.3% to ₹7.84 Tn (capex ₹2.19 Tn); no 'big jump' dashed hopes, BEL -6.02%/HAL watchlist; but DAP/DPM aids long-term.
- Bharat Dynamics, Waaree Energies, Ather in focus; textiles ₹5k Cr indirect support.
- Impact: Oversold bounce potential; avoid fresh bets pre-clarity.
Pharma Lifeline Intact Amid Volatility
- ₹10k Cr 'Bio Pharma Shakti' (5 yrs), health ₹1.06 Tn, 17 drug duty exemptions; Cipla +1.44%, Sun Pharma +0.86%, Dr Reddy's resilient; Biocon stocks watch.
- Exports/biologics thrust reduces imports; Q3 trends strong.
- Impact: Sector +1.2%; top resilient play, add on dips.
IT Cushion Holds with Tax Tweaks
- TCS threshold/LRS/education to 2%; safe harbour hikes aid; Wipro +2.12%, TCS +1.74%; HCL -1.26% lags but Infosys Q3 cues (net -2.2% YoY, rev +3.2% USD) mixed.
- Labour code costs (Infosys ₹1,289 Cr) pressure margins, but growth resilient.
- Impact: Nifty IT +0.59%; defensive buy amid vol ₹4,197 Cr.
PSU Bank Rout Eases on Borrowing News
- SBI -5.31%, but gross borrow ₹17.2 Tn peg shifts focus; repo cut hopes mitigate (CPI 1.33%).
- ICICI Bank recos; banks vol ₹5,686 Cr.
- Impact: Dip-buy PSUs pre-RBI; Nifty Bank >59,500 tgt 60.4k.
RBI MPC Looming (Feb 4-6) – Key Catalyst
- 25 bps cut odds 80% (poll consensus hold/status quo mixed); inflation 1.33% Dec, Jan data Feb 12; GDP Q3 7% proj.
- Comfort on 4% avg FY27 inf; growth pickup GST/easing aided.
- Impact: Supports recovery Feb 2+; hold rates if US data hawkish.
Q3 Earnings Fireworks Today/Week
- Today: Bajaj Housing, Hyundai India, Indus Towers, PB Fintech, Railtel, Tata Chemicals, Latent View (Sun); Airtel/Suzlon/SBI/LIC/IOC Feb 5.
- Mixed Q3: IT margins squeeze, financials/pharma up.
- Impact: Stock-specific moves; watch Airtel ARPU/SBI loans.
Other Buzz: Sin Taxes & Global Ties
- ITC/Godfrey Phillips/VST (-4%+ Feb1) on cigarette excise up; Bitcoin <$80k, gold down weighs risk assets.
- Stocks watch: Elitecon, Orient Tech (ASM), Manorama (ASM).
- Overall Impact: Selective resilient buys (pharma/IT/infra); mcap stable ₹448 Tn; GIFT signals mild rebound, but STT/RBI key.
Foreign Indices Movements that Influenced Indian Markets
Asia-Pacific mixed, US cautious; GIFT +0.13% reflects.
| Index | Feb 1/2 Change | Influence on India |
| S&P 500 US | -0.43% | Risk-off pre-Fed; largecap caution |
| Nasdaq | -0.94% | IT selective support |
| Dow | -0.36% | Mild; banks watch Fed |
| Nikkei Japan | +0.75% | Positive open cue for Nifty |
| Hang Seng | -1.34% | China drag on metals |
| Kospi SK | -2.63% | Tariff fears hit exports |
| Shanghai CN | Flat | Commodity stability |
Nikkei aided flat open; US tech dip caps upside.
Performance Overview
Top 10 Stocks to Buy NSE/BSE for 2026
- Bharti Airtel (P/E 25, yield 0.5%): 5G ARPU +15%; telecom data boom.
- State Bank India (P/E 11, yield 1.2%): 13% loan growth; repo tailwind.
- HCL Tech (PEG 0.9, yield 3%): AI deals; Q2 margins resilient.
- Eternal Ltd (PEG <1): Quick commerce; 30% CAGR revenue.
- Biocon (PEG 0.8): Biosimilars exports; Budget biologics.
- TVS Motor (P/E 40): EV penetration 25% growth.
- Max Financial: Insurance doubling; undervalued.
- JK Cement: Capex infra; capacity 20% up.
- Poonawalla Fincorp: NBFC retail; high ROE.
- Privi Speciality (yield 1%): Fragrance exports; margins 18%.
Focus: GDP-linked growth, low PEG bluechips.
Performance Overview Continued: Feb 1 Top 10 Gainers/Losers (Nifty Focus)
| Top Gainers (Feb 1) | % Chg | Analysis |
| Wipro | +2.12% | IT safe harbour |
| TCS | +1.74% | Tech resilience |
| Max Health | +1.82% | Healthcare Budget |
| Cipla | +1.44% | Pharma fund |
| Sun Pharma | +0.86% | Biologics boost |
| Infy | +0.06% | Selective buy |
| Kotak Bank | -0.04% | Stable pvt bank |
| Indigo | -0.12% | Aviation hold |
| SBILife | -1.08% | Ins dip |
| (Broadly pharma/IT) | <2% | Sector outperf. |
Top 10 Losers (Nifty Focus)
| Top Losers (Feb 1) | % Chg | Analysis |
| BEL | -6.02% | Defence miss |
| Hindalco | -5.78% | Metals slump |
| ONGC | -5.50% | Oil pressure |
| SBI | -5.31% | PSU tax hit |
| Adani Ports | -5.06% | Infra caution |
| Coal India | -4.87% | Energy drag |
| ITC | -4.35% | Sin tax |
| Tata Consum | -4.31% | FMCG weak |
| Nestle | -4.61% | Consumer sell |
| Reliance | -3.77% | Conglo broad |
Pharma/IT gained; PSUs/metals tanked.
Sector Performance: IT, Banking, Pharma, Consumer Goods
Q2FY26 earnings: 9.2% rev, OPM +140bps to 16.1% (ICRA).
| Sector | Feb 1% Chg | YTD 2026 | Earnings Drivers/Mcaps |
| IT | +0.59% (Nifty IT 38k) | +12% | Safe harbour; margins steady; vol ₹4,197 Cr |
| Banking | -2.64% (Bank Nifty -2%) | +4% | STT PSU hit; SBI/SBIN down; ₹5,686 Cr vol |
| Pharma | +1.2% avg | +15% | Biologics ₹10k Cr; Sun/Cipla up; exports |
| Consumer Goods | -2.5% (FMCG drag) | +7% | Sin taxes ITC/Nestle; premiumisation offset |
IT/pharma lead recovery; banking eyes RBI.
Analysis and Recommendations
Post-Budget dip offers entry: Nifty 24,500 crucial; RBI cut to lift sentiment amid 1.33% CPI, 7.4% GDP. Actionable: Buy quality dips, hedge VIX; avoid overleveraged F&O post-STT.
Diversified Portfolios by Risk:
Low Risk: 45% Banks (SBI/HDFC, P/E 11, yield 1.2%; pros: dividends, stability; cons: vol; drivers: 13% loans Q3). 30% IT (TCS, yield 3%; pros: global; cons: rupee). 25% Pharma. Expected 12% ann ret.
Medium Risk: 35% Airtel/Biocon (PEG<1; pros: growth 20%; cons: reg; Q2 rev +9%). 30% Infra (L&T), 35% cons. 15-18% pot.
High Risk: 40% Midcaps (Eternal/JK Cem; pros: 25% CAGR; cons: liquid; Budget capex).
Stock Recommendations for Today (Feb 2, 2026, 9:15 AM IST Open)
Markets eye flat-positive start (GIFT Nifty 24,888 +0.13%) post-Budget STT shock; focus dips in infra/pharma/IT, avoid brokers/defence vol; Nifty range 24,650-25,000. Tailwinds: RBI MPC cut odds 80%, Q3 earnings (Hyundai/Airtel week). Here's actionable picks from analysts (Motilal Oswal, Sunday Guardian, ET Now), with TP, rationale, risks – scale in 9:30-10 AM.
Buy Calls (Dip Buys on Budget Resilience/Growth)
- ICICI Bank (CMP ₹1,334 | TP ₹1,750 | Upside 31%)
Strong retail/corporate franchise, RoA/RoE 2.3%/16.1% FY27E; fiscal 4.3% aids liquidity; buy >₹1,340, SL ₹1,300. Risk: Slow NIM. - APL Apollo Tubes (CMP ₹2,047 | TP ₹2,350 | Upside 15%)
Infra capex ₹12.2 Tn king; capacity/geography expansion, value-add prods; buy dips >₹2,000, SL ₹1,950. Risk: Steel prices. - RVNL (Rail Vikas Nigam) (CMP ₹500 | TP ₹650)
7 high-speed rails, freight corridors; order book boom; buy >₹510, SL ₹480. Motilal pick; Q3 rev strong. Risk: Execution delays. - Apollo Hospitals (CMP ₹7,500 | TP ₹9,015)
Health ₹1.06 Tn + biologics; hosp capex aligns; buy >₹7,550, SL ₹7,300. Defensive post-Budget. - Biocon (CMP ₹350 | TP ₹450)
₹10k Cr Bio Shakti biosimilars; exports up; buy >₹355, SL ₹340. Pharma leader. - Mahindra & Mahindra (CMP ₹2,800 | TP ₹4,521)
Farm mech/infra clusters, auto Jan sales; EV/tractors; buy >₹2,850, SL ₹2,700. - Zensar Technologies (CMP ₹750 | TP ₹830)
AI/semicon PLI ₹40k Cr ISM 2.0; IT intelligence shift; buy >₹760, SL ₹730. - Larsen & Toubro (CMP ₹3,600 | TP ₹4,200)
Capex multiplier; roads/rails; post-dip buy >₹3,650, SL ₹3,500.
Accumulate/Watch (Selective Momentum)
- HDFC Bank/ICICI Bank Pair: Fiscal glide, inflows; watch >₹1,700/1,340.
- Tata Power/NTPC: Solar/nuclear/green H2; renewables push.
- Raymond: Textile incentives/parks.
- Zomato: Gig economy security.
Final Thought
February 2, 2026, opens as a pivotal test for Indian markets: Budget 2026's STT pain (F&O costs up 20-30%) fades against ₹12.2 Tn capex firepower, 7.4% FY26 GDP trajectory, December CPI at 1.33%, and RBI repo at 5.25% with 80% cut odds Feb 4-6. Unique data insights shine through – IT sector +0.59% with ₹4,197 Cr volume despite vol, pharma leading gainers (Cipla +1.44%, Sun Pharma +0.86%), while PSUs like SBI (-5.31%) offer dip value pre-RBI.
Bluechip stock picks like SBI, Airtel, and ICICI Bank stand out long-term amid infra/health tailwinds and fiscal 4.3% discipline, promising 15-20% upside for patient investors eyeing market prediction India. Inflation trends India remain benign, supporting recovery consolidation in Nifty 24,500-25,500.
Disclaimer: The use of any third-party business logos in this content is for informational purposes only and does not imply endorsement or affiliation. All logos are the property of their respective owners, and their use complies with fair use guidelines. For official information, refer to the respective company’s website.
Disclaimer: This analysis on Indian stock market trends is for educational and informational purposes only and does not constitute financial, investment, legal, tax, or accounting advice. Markets are volatile; past performance isn't indicative of future results. Consult a qualified financial advisor before making investment decisions.
